Simple Science

Cutting edge science explained simply

# Biology# Biochemistry

Natural Products and Their Role in Medicine

Exploring the importance of natural products and their potential health benefits.

― 4 min read


Natural Products' ImpactNatural Products' Impacton Healthmedicinal potential.New insights into RiPPs and their
Table of Contents

Natural products are substances that come from plants, animals, and microorganisms. These products are important because they contain a variety of compounds that can have beneficial effects on health and society. Scientists are excited about finding new natural products because they can lead to new medicines and treatments.

Advances in Science and Technology

With the growth of genomic databases, scientists can now look at the genetic information of many organisms more easily. This helps them find new ways to produce valuable compounds from natural sources. In recent years, scientists have developed new tools that allow them to study these compounds in detail. The use of enzymes from natural products has become increasingly important in creating new and effective processes for producing chemicals.

Ribosomally Synthesized Peptides (RiPPs)

One exciting area of natural products is ribosomally synthesized and post-translationally modified peptides, known as RiPPs. RiPPs are a large family of natural products that are made by living organisms and then modified after they are created. These products have many different structures and can have a wide range of health benefits, including fighting infections and certain diseases.

RiPPs often start as precursor peptides, which have regions that help attract the enzymes that modify them. These modifications can create new structures that have unique activities. For example, RiPPs can be effective against bacteria, viruses, fungi, and even cancer. Scientists have found many different types of RiPPs, and they believe that there are many more yet to be discovered.

Finding New RiPPs

To find new RiPPs, researchers use bioinformatics tools to search for specific protein domains that are often found in RiPP biosynthetic gene clusters (BGCs). These domains are called RiPP precursor recognition elements (RREs). RREs help identify which genes are involved in creating RiPPs. Although these domains can be challenging to detect due to their small size, scientists have developed methods to catalog them effectively.

Once these domains are identified, researchers can prioritize which BGCs to study further. This allows them to focus on identifying enzymes and understanding how new RiPPs are formed.

The Study of Burkholderia thailandensis

A recent study focused on a specific organism called Burkholderia thailandensis E264. This organism has a unique BGC that encodes several enzymes capable of creating a new class of RiPPs. Researchers discovered that these enzymes work together to modify a precursor peptide into a novel structure.

The main enzymes include a special type of enzyme known as a multinuclear non-heme iron-dependent oxidative enzyme (MNIO) and others that work in tandem to create a new product. By studying the actions of these enzymes on the precursor peptide, researchers observed interesting chemical reactions that produced previously unknown structures.

Techniques Used in the Study

To study these enzymes and their products, researchers used various laboratory techniques. They expressed the precursor peptide and different modifying enzymes in the laboratory, purifying the resulting products for analysis. Mass spectrometry was one key technique, allowing researchers to determine the masses of the compounds produced and to identify the specific modifications that had occurred.

Additionally, nuclear magnetic resonance (NMR) spectroscopy was used to study the structures of the modified peptides. This technique helped researchers gather detailed information about how the different atoms in the peptide are arranged.

Discovering New Products

From their studies, researchers were able to identify that one enzyme, ApyD, was responsible for adding a methyl group (a small chemical unit) to a specific part of the precursor peptide. Another enzyme, ApyO, created a biaryl crosslink between two tyrosine residues-making a new bond that wasn't present in the original peptide.

Further modifications were made by ApyHI, which worked on the peptide’s end, turning aspartic acid into a different structure. This conversion resulted in a new type of compound that had not been seen before in other natural products.

The Importance of Host Organisms

While E. coli has long been the go-to organism for studying these types of compounds, researchers found that using Burkholderia sp. FERM BP-3421 allowed them to delve deeper into the RiPP chemistry. This organism proved to be more effective in producing active forms of the enzymes involved in generating the new RiPPs, showcasing the importance of selecting the right host for enzymatic studies.

Conclusion

This work highlights the significance of natural products and their potential to lead to new discoveries in medicine and biology. By integrating bioinformatics and experimental techniques, researchers can uncover the complexities of natural product biosynthesis. The findings of this research could pave the way for future studies aimed at discovering even more natural products with promising medicinal properties. Overall, this research opens doors to new avenues in the study of peptides and their applications in healthcare.

Original Source

Title: Discovery of biaryl macrocyclic peptides with C-terminal β-amino-α-keto acid groups

Abstract: Advances in genome sequencing and bioinformatics methods have identified a myriad of biosynthetic gene clusters (BGCs) encoding uncharacterized molecules. By mining genomes for BGCs containing a prevalent peptide-binding domain used for the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs), we uncovered a new class involving modifications installed by a cytochrome P450, a multi-nuclear iron-dependent non-heme oxidative enzyme (MNIO, formerly DUF692), a cobalamin- and radical S-adenosyl-L-methionine-dependent enzyme (B12-rSAM), and a methyltransferase. All enzymes encoded by the BGC were functionally expressed in Burkholderia sp. FERM BP-3421. Structural characterization with 2D-NMR and Marfeys method on the resulting RiPP demonstrated that the P450 enzyme catalyzed the formation of a biaryl C-C crosslink between two Tyr residues with the B12-rSAM generating {beta}-methyltyrosine. The MNIO transformed a C-terminal Asp residue into aminopyruvic acid while the methyltransferase acted on the {beta}-carbon of the -keto acid. Exciton-coupled circular dichroism spectroscopy and microcrystal electron diffraction (MicroED) were used to elucidate the stereochemical configurations of the atropisomer that formed upon biaryl crosslinking. The conserved Cys residue in the precursor peptide was not modified as in all other characterized MNIO-containing BGCs; However, mutational analyses demonstrated that it was essential for the MNIO activity on the C-terminal Asp. To the best of our knowledge, the MNIO featured in this pathway is the first to modify a residue other than Cys. This study underscores the utility of genome mining to discover new macrocyclic RiPPs and that RiPPs remain a significant source of previously undiscovered enzyme chemistry.

Authors: Wilfred van der Donk, D. T. Nguyen, L. Zhu, D. L. Gray, T. Woods, C. Padhi, K. M. Flatt, D. A. Mitchell

Last Update: 2024-01-17 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2023.10.30.564719

Source PDF: https://www.biorxiv.org/content/10.1101/2023.10.30.564719.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles